96 related articles for article (PubMed ID: 23820930)
41. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
42. Cancer risk in association with Parkinson disease: a population-based study.
Becker C; Brobert GP; Johansson S; Jick SS; Meier CR
Parkinsonism Relat Disord; 2010 Mar; 16(3):186-90. PubMed ID: 19945903
[TBL] [Abstract][Full Text] [Related]
43. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan.
Cheng KC; Chen YL; Lai SW; Tsai PY; Sung FC
BMC Gastroenterol; 2012 Dec; 12():177. PubMed ID: 23234272
[TBL] [Abstract][Full Text] [Related]
44. Statin use and the risk of esophageal cancer: a population-based case-control study.
Chan TF; Chiu HF; Wu CH; Lin CL; Yang CY
Expert Opin Drug Saf; 2013 May; 12(3):293-8. PubMed ID: 23470154
[TBL] [Abstract][Full Text] [Related]
45. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Lindblad M; Lagergren J; García Rodríguez LA
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):444-50. PubMed ID: 15734971
[TBL] [Abstract][Full Text] [Related]
46. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
47. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
48. Lithium, antipsychotics, and risk of psoriasis.
Brauchli YB; Jick SS; Curtin F; Meier CR
J Clin Psychopharmacol; 2009 Apr; 29(2):134-40. PubMed ID: 19512974
[TBL] [Abstract][Full Text] [Related]
49. NSAID use and risk of Parkinson disease: a population-based case-control study.
Becker C; Jick SS; Meier CR
Eur J Neurol; 2011 Nov; 18(11):1336-42. PubMed ID: 21457177
[TBL] [Abstract][Full Text] [Related]
50. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE; Lu Y; Lagergren P; Lagergren J
Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349
[TBL] [Abstract][Full Text] [Related]
52. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
[TBL] [Abstract][Full Text] [Related]
53. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.
de Jong RGPJ; Peeters PJHL; Burden AM; de Bruin ML; Haak HR; Masclee AAM; de Vries F; Janssen-Heijnen MLG
Cancer Epidemiol; 2018 Jun; 54():104-111. PubMed ID: 29705628
[TBL] [Abstract][Full Text] [Related]
54. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study.
Morgan CL; Mukherjee J; Jenkins-Jones S; Holden SE; Currie CJ
Diabetes Obes Metab; 2014 Oct; 16(10):957-62. PubMed ID: 24720708
[TBL] [Abstract][Full Text] [Related]
55. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.
Brauchli YB; Jick SS; Curtin F; Meier CR
Br J Dermatol; 2008 Jun; 158(6):1299-307. PubMed ID: 18410416
[TBL] [Abstract][Full Text] [Related]
56. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
Chow WH; Finkle WD; McLaughlin JK; Frankl H; Ziel HK; Fraumeni JF
JAMA; 1995 Aug; 274(6):474-7. PubMed ID: 7629956
[TBL] [Abstract][Full Text] [Related]
57. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.
Wang QL; Santoni G; Lagergren J
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37314979
[TBL] [Abstract][Full Text] [Related]
58. Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors.
Becker C; Schneider C; Aballéa S; Bailey C; Bourne R; Jick S; Meier C
Eye (Lond); 2018 Jun; 32(6):1028-1035. PubMed ID: 29386666
[TBL] [Abstract][Full Text] [Related]
59. ACE inhibitor use and risk of cataract: a case-control analysis.
Becker C; Jick SS; Meier CR
Br J Ophthalmol; 2019 Nov; 103(11):1561-1565. PubMed ID: 30733210
[TBL] [Abstract][Full Text] [Related]
60. Risk of incident depression in patients with Parkinson disease in the UK.
Becker C; Brobert GP; Johansson S; Jick SS; Meier CR
Eur J Neurol; 2011 Mar; 18(3):448-53. PubMed ID: 20722714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
